Home > Insider Trading > Filing (0001140361-15-043956)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1293818	Opgen Inc	OPGN,OPGNW	Services-Medical Laboratories (8071)	061614015

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1020741	Fa Evan/ Jones	C/O Opgen, Inc. 708 Quince Orchard Road, Suite 205 Gaithersburg MD 20878	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-12-04	300	$1.76	2,929,432	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2015-12-07	600	$1.79	2,930,032	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	131,156	Indirect	By spouse

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.71 to $1.82, inclusive. The reporting person undertakes to provide to OpGen, Inc., any security holder of OpGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) of this Form 4.
The securities are directly held by jVen Capital, LLC ("jVen Capital"). Mr. Jones is managing member of jVen Capital and may be deemed to have voting and dispositive power over the shares owned by jVen Capital.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.74 to $1.83, inclusive.